- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07715695
Evaluation of a Scalable Educational Intervention for Adjustment and Coping to Vision Loss
July 16, 2026 updated by: Ali S Raza, MD, PhD, Brigham and Women's Hospital
The goal of this interventional study is to learn if an educational intervention improves awareness in people experiencing visual loss. The main question it aim to answer is:
- Will participants have an improved awareness of shared experiences regarding themes such as grief and isolation?
Participants will be asked to answer questions, engage with an audiovisual educational intervention, and then answer additional questions.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Research Coordinator
- Phone Number: 617-732-6753
- Email: ophthalmic-psychiatry-recruitment@massgeneralbrigham.org
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- New England College of Optometry
-
Principal Investigator:
- Micaela Gobeille, OD, MS, FAAO, Dipl AAO LV
-
Sub-Investigator:
- Nicole Ross, OD, MSc, FAAO, Dipl AAO LV
-
Boston, Massachusetts, United States, 02115
- Brigham and Women's Hospital, Mass General Brigham
-
Principal Investigator:
- Ali S Raza, MD, PhD
-
Sub-Investigator:
- Pamela B Mahon, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- have capacity to provide informed consent
- have had a visit within a low-vision rehabilitation clinic
Exclusion Criteria:
- are unable to engage with the audiovisual educational intervention
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Educational Intervention Arm
|
A brief audiovisual educational intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in Educational Awareness of Shared Themes as Measured by Likert-scale Questions
Time Frame: From baseline to completion of post-intervention questions (e.g., within 1 week).
|
Higher values (or increases relative to baseline) correspond to better outcomes, with each question having a minimum value of 1 and a maximum value of 5.
|
From baseline to completion of post-intervention questions (e.g., within 1 week).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in Screening Measures of Depression and Anxiety as Measured by the Patient Health Questionnaire 4 (PHQ-4)
Time Frame: From baseline to completion of post-intervention questions (e.g., within 1 week).
|
Lower values (or decreases relative to baseline) correspond to better outcomes, with each question having a minimum value of 0 and a maximum value of 3.
|
From baseline to completion of post-intervention questions (e.g., within 1 week).
|
|
Change from Baseline of Vision-Related Wellbeing as Measured by the Visual Function Questionnaire 25 (VFQ-25) Socioemotional Wellbeing Subscale
Time Frame: From baseline to completion of post-intervention questions (e.g., within 1 week).
|
From baseline to completion of post-intervention questions (e.g., within 1 week).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ali S Raza, MD, PhD, Brigham and Women's Hospital, Mass General Brigham
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
July 20, 2026
Primary Completion (Estimated)
May 30, 2027
Study Completion (Estimated)
June 30, 2027
Study Registration Dates
First Submitted
July 1, 2026
First Submitted That Met QC Criteria
July 16, 2026
First Posted (Actual)
July 20, 2026
Study Record Updates
Last Update Posted (Actual)
July 20, 2026
Last Update Submitted That Met QC Criteria
July 16, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2026P001151
- HADLEY-RFA-2026-01 (Other Grant/Funding Number: Hadley Foundation, Inc.)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.